The primary objective of this substudy was to assess mean relative change from baseline in liver fat (LF) at 24 weeks in participants from that study with metabolic dysfunction-associated steatotic liver disease and 10% of LF
Patients should remain aware of symptoms such as agitation, confusion, rapid heart rate, high blood pressure, dilated pupils, muscle rigidity, or fever, and seek immediate medical attention if these occur
Additionally, the relative lean mass and subcutaneous fat mass was found to maintain control levels in all groups associated with the peptide
Storage and Stability: Over-diluting can shorten the peptides lifespan, while under-diluting can make accurate dosing frustrating
This visceral fat specificity, rather than subcutaneous fat reduction, is mechanistically linked to GHs preferential lipolytic effects on visceral adipocytes